Weight-loss drugs, like GLP-1s, also show blood pressure benefits
Obesity is a chronic condition that affects more than two in five adults in the United States. The…
Obesity is a chronic condition that affects more than two in five adults in the United States. The…
Biological aging refers to how well the body functions as it ages, which may not always be the…
On Monday, May 12, 2026, an international panel of experts dubbed the Global Name Change Consortium announced —…
As of 2022, there were about 2.3 million women around the world newly diagnosed with breast cancer, and…
In perimenopause, the female body begins its transition into menopause, which signals the end of fertility and the…
Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist that mimics a hormone to increase insulin secretion, slow…
Which came first, depression or insomnia? And why do some people with depression sleep too little and others…
Vitamin D, also known as the sunshine vitamin, is often touted as a cure-all, but does its hype…
Over the last few years, glucagon-like peptide-1 (GLP-1) receptor agonists have been growing in popularity for not only…
The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults…